Should I buy Envista Holdings (NVST) stock or is it too late?

Envista Holdings · Health Care · price $27
Logo Envista HoldingsSee the full Envista Holdings (NVST) profile
⭐ What the most reliable analysts say

No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.

Firm-by-firm track record on Envista Holdings

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
JP Morgan40 %+60.5 %5$29 +6%
Stifel50 %+5.5 %6$31 +13%
Morgan Stanley0 %-19.5 %9$21 -23%
In short — Should you invest in Envista Holdings? Is it too late, still worth it? Analysts are split (38% buy, median target $29, i.e. +6%), and the most reliable on NVST targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • The most reliable firm on NVST, Evercore ISI Group (100% hit rate, 4 scored calls), targets $33 (call made on May 7, 2026, maturing on May 7, 2027) (+20%) in its most recent call, and $30 (call made on April 8, 2026, maturing on April 8, 2027) (+9%) in the one coming due soonest.

⚠️ Reasons to hesitate

  • The consensus is not unanimous: of 8 ratings, 5 are neutral.
  • Limited upside: the median target is only +6% from the current price.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.
  • No dividend: your return depends only on price appreciation.

The analyst consensus on NVST

Median target $29 (+6%) · 8 ratings · Hold consensus

Strong Buy00%
Buy338%
Hold563%
Sell00%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Envista Holdings now?

We won't decide for you. The facts: 38% of analysts rate it a buy, median target $29 (+6%), and Evercore ISI Group (most reliable on NVST, 100%) targets $33. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Envista Holdings?

Not according to analysts: the median target ($29) is still +6% above the current price ($27) (most reliable on NVST: Evercore ISI Group, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Envista Holdings still worth investing in?

It depends on the gap between the price ($27) and its estimated value: analysts target $29 on median (+6%), with 38% buys (most reliable on NVST: Evercore ISI Group, 100%). Cross-check with their real reliability on NVST and the cautions above. Information, not advice.

What's the main risk in buying NVST?

The consensus is not unanimous: of 8 ratings, 5 are neutral.

→ Go deeper: the full Envista Holdings profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)